You know the commercial. You've seen it a thousand times. A sunny backyard, a picture-perfect group of friends and family laughing over a barbecue, a golden retriever wandering through, and a warm, soothing narrator introducing a brand-new medication for a condition you've never heard of, with a name nobody can pronounce.
Then comes the fine print. It starts gently. It never stops. By the end, the narrator has calmly listed liver failure, vision loss, and “certain forms of cancer” — all while everyone keeps smiling, and the music never skips a beat.
I finally decided to answer one of those commercials in kind. Meet Xyphlorrza, the first and only treatment for Chronic Potluck Dysphoria — a serious condition in which the sight of a covered casserole dish can trigger uncontrollable sweating, involuntary humming, and the persistent feeling that everyone knows you brought store-bought.
Let me be clear about one thing: drug companies have every right to advertise, and I have every right to laugh at the results. Free speech and free enterprise work both ways, and I'm a fan of both. But somewhere between the barbecue and the side effects, these commercials became their own genre — the most cheerful sixty seconds on television spent describing the ways you might die.
So I kept everything that makes them work — the sunshine, the soothing voice, the gentle guitar, the hopeful faces turning toward the camera — and simply let the guests actually hear what the narrator is saying. Things go downhill from there. Quickly. And then they catch fire.
This was my first real attempt at an AI video with a full script, and it was a genuine education. The script went through more rewrites than I can count, the video took eight or ten attempts to get right, and the scrolling fine print cost me a very long day learning the professional video editor DaVinci Resolve from scratch — layers, opacity, keyframes, and one project that vanished into thin air along the way. A few AI “hallucinations” survived into the final cut. Consider them side effects.